Biotherapeutics

Biotherapeutics

Biotherapeutics

NIMML uses disruptive innovation to tackle global health challenges in infectious, immune-mediated & chronic inflammatory diseasesour site
Raised
$800k
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$800,000
Grant - 2017
Virginia Catalyst
Undisclosed amount
Venture capital - 2014
Team Size
1–10
Employees
Location
Headquarters
WSJ Venture Capital

Gene Therapy Startup CODA Biotherapeutics Boosts Funding

FinSMEs

A2 Biotherapeutics Raises $57M in Series A Funding

TechCrunch

Coda Biotherapeutics is developing a cure for pain

FinSMEs

Noveome Biotherapeutics Completes $15M Series D Financing

$300,000 Grant
vabio

Virginia Catalyst Awarded $2.825M in Grants to 6 Collaborative Projects - Virginia Bio

The Motley Fool

Why Northwest Biotherapeutics, Accuray, and U.S. Steel Slumped Today --

Stock markets
The Motley Fool

Why Atara Biotherapeutics Inc. Shares Are Getting Mauled Today --

Stock markets Health
$13,500,000 Venture capital (Series B)
FinSMEs

Atara Biotherapeutics Holds $13.5M Second Close of Series B Financing

$38,500,000 Venture capital (Series B)
FinSMEs

Atara Biotherapeutics Secures $38.5M in Series B Financing